Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Euro Medium Term Note Programme

3 Mar 2026 16:57

RNS Number : 1884V
Babcock International Group PLC
03 March 2026
 

3 March 2026

 

 

Babcock International Group PLC

 

Publication of Base Prospectus

 

The following base prospectus (the "Prospectus") has been approved by the Financial Conduct Authority and is available for viewing:

 

The Prospectus dated 3 March 2026 relating to the Babcock International Group PLC £3,000,000,000 Euro Medium Term Note Programme.

 

 

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

 

To view the Prospectus, please paste the following URL into the address bar of your browser:

 

https://www.babcockinternational.com/investors/debt-investors/emtn-programme/

 

A copy of the Prospectus will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

For further information please contact:

 

Babcock International Group PLC

Andrew Gollan Samuel MacGregor

Director of Investor Relations Investor Relations Manager

Tel: +44 7936 039 004 Tel: +44 7730 753 159

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and securities in bearer form are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered, sold or (in the case of securities in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIJJMFTMTAMBJF
Date   Source Headline
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202511:36 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202512:02 pmRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20255:00 pmRNSNotice of AGM
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20256:27 pmRNSLaunch of Share Buyback Programme
7th Jul 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jul 20253:57 pmRNSDirector/PDMR Shareholding
1st Jul 20255:41 pmRNSFinal Results
25th Jun 20257:00 amRNSPreliminary results for the year ended 31.03.2025
17th Jun 20253:30 pmRNSHolding(s) in Company
10th Jun 20251:11 pmRNSHolding(s) in Company
9th Jun 20254:23 pmRNSDirector Announcement
5th Jun 20259:00 amRNSDirectorate Change
20th May 202512:48 pmRNSBabcock host Cavendish Nuclear teach-in event
23rd Apr 20257:00 amRNSFY25 Post-close Trading Update
26th Mar 20257:30 amRNSBabcock awarded five-year British Army contract
19th Mar 20256:00 pmRNSHargreaves Lansdown
7th Feb 20253:16 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSQ3 trading update and upgrade of FY25 expectations
30th Jan 20254:05 pmRNSHolding(s) in Company
21st Jan 20253:55 pmRNSDirector/PDMR Shareholding
27th Nov 202411:37 amRNSDirector/PDMR Shareholding
18th Nov 20243:06 pmRNSDirector/PDMR Shareholding
18th Nov 20242:34 pmRNSChange of Record Date for Interim Dividend
14th Nov 20244:33 pmRNSDirector/PDMR Shareholding
14th Nov 202411:50 amRNSDirector announcement
13th Nov 20247:00 amRNSResults for the six months ended 30 September 2024
4th Oct 20242:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20244:13 pmRNSDirector/PDMR Shareholding
1st Oct 20243:04 pmRNSHolding(s) in Company
30th Sep 20243:41 pmRNSDirector/PDMR Shareholding
26th Sep 20242:49 pmRNSDirector/PDMR Shareholding
19th Sep 20243:35 pmRNSResult of AGM
19th Sep 20247:00 amRNSAGM trading update
6th Sep 202411:48 amRNSDirector/PDMR Shareholding
29th Aug 20244:33 pmRNSDirector/PDMR Shareholding - Replacement
29th Aug 20241:26 pmRNSDirector/PDMR Shareholding
15th Aug 20241:01 pmRNSNotice of AGM
7th Aug 20249:44 amRNSDirector/PDMR Shareholding
6th Aug 202411:28 amRNSDirector/PDMR Shareholding
5th Aug 20244:26 pmRNSDirector/PDMR Shareholding
2nd Aug 202412:02 pmRNSDirector/PDMR Shareholding
1st Aug 20243:48 pmRNSDirector/PDMR Shareholding
30th Jul 20249:53 amRNSAnnual Financial Report
26th Jul 20247:00 amRNSFull year results for the year ended 31 March 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.